Drug Can Curb Ewing’s Sarcoma Growth 24 Dec 2009 An early study of the drug figitumumab has found that in some patients it can curb the growth of Ewing’s sarcoma - a cancer which affects mainly teenage boys. The study was led by Dr Johann de Bono, from The Institute of Cancer Research and The Royal Marsden Hospital, and funded by Pfizer, who developed the drug. Find out more Show/Hide